A phase 3 study of gemtuzumab ozogamicin during induction and postconsolidation therapy in younger patients with acute myeloid leukemiaStephen H. Petersdorf, Frederick R. Appelbaum, Patrick J. Stiff et al.|Blood|2013Cited by 632